logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
27/08/2025
In the Hong Kong stock market, application software stocks showed strength at the beginning of trading. Lianyi Rong Technology rose 17%, Graffiti Intelligence rose nearly 10%, Tianrun Cloud rose over 7%, Inspur Digital Enterprise and Kingdee International rose more than 5%.
Latest
3 m ago
Haohen Motors and Electronics: Currently, the company has sufficient orders in hand.
3 m ago
The trading volume of the three cities Shanghai, Shenzhen, and Beijing exceeded 1.9 trillion yuan, which was 752 billion yuan higher than the same time the previous day.
3 m ago
Haowen Auto Electric: Has reached a strategic chip cooperation with NVIDIA and fully entered the development of robot brain control system.
4 m ago
Every economic AI flash news, Huayuan Securities released a research report on August 27th, giving Wanmei Biology (603983.SH) a buy rating. The reasons for the rating mainly include: 1) Continuously promoting the high-quality development of dual-brand synergy; 2) The online channel is gaining momentum, and refined operation is carried out on multiple platforms; 3) The company's profitability has decreased slightly, and the sales expense ratio has continued to rise. (Daily Economic News)
4 m ago
Hong Kong-listed innovative pharmaceutical stocks continue to decline, with many stocks such as Zhaoyan Pharmaceuticals falling by more than 3%.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.